National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant interleukin-4
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-4 (IL-4). Produced primarily by activated T-cells, IL-4 binds to and activates its cell-surface receptor, stimulating the proliferation and differentiation of activated B-cells and enhancing their ability to present antigens to T-cells. As a potential immunotherapeutic agent, recombinant IL-4 also augments the effects of other cytokines on dendritic cells (DC), cytotoxic T lymphocytes (CTL), and tumor-infiltrating lymphocytes (TIL). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:B Cell Proliferating Factor
B-Cell Growth Factor
B-Cell Stimulating Factor
B-Cell Stimulatory Factor 1
Mast Cell Growth Factor-2
recombinant human IL-4
T-Cell Growth Factor 2
Abbreviations:BCGF
BCSF 1
IL-4
MCGF 2
rhIL-4



Previous:recombinant interleukin-1-beta, recombinant interleukin-11, recombinant interleukin-12, recombinant interleukin-18, recombinant interleukin-3
Next:recombinant interleukin-6, recombinant interleukin-7, recombinant macrophage colony-stimulating factor, recombinant MAGE-3.1 antigen, recombinant modified vaccinia Ankara-5T4 vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov